![Brian Hilberdink](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Hilberdink formerly worked at BIOTECanada, as Director, Novo Nordisk Canada, Inc., as President, and Leo Pharma, Inc., as President & Executive Vice President from 2022 to 2025.
Mr. Hilberdink received his undergraduate degree from Queen's University.
| Sociétés | Poste | Fin |
|---|---|---|
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | President | 11/02/2025 |
Novo Nordisk Canada, Inc.
 Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | President | - |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
Novo Nordisk Canada, Inc.
Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
